title: Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995.
authors.forename: K P
authors.initials: KP
authors.lastname: Johnson
authors.forename: B R
authors.initials: BR
authors.lastname: Brooks
authors.forename: J A
authors.initials: JA
authors.lastname: Cohen
authors.forename: C C
authors.initials: CC
authors.lastname: Ford
authors.forename: J
authors.initials: J
authors.lastname: Goldstein
authors.forename: R P
authors.initials: RP
authors.lastname: Lisak
authors.forename: L W
authors.initials: LW
authors.lastname: Myers
authors.forename: H S
authors.initials: HS
authors.lastname: Panitch
authors.forename: J W
authors.initials: JW
authors.lastname: Rose
authors.forename: R B
authors.initials: RB
authors.lastname: Schiffer
authors.forename: T
authors.initials: T
authors.lastname: Vollmer
authors.forename: L P
authors.initials: LP
authors.lastname: Weiner
authors.forename: J S
authors.initials: JS
authors.lastname: Wolinsky
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000266:history; D004185:Disability Evaluation; D005260:Female; D000068717:Glatiramer Acetate; D049673:History, 20th Century; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic / Q000266:history; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000266:history*; D010455:Peptides / Q000266:history* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000266:history
chemical_list: D010455:Peptides; D000068717:Glatiramer Acetate